Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
21.01
-0.03 (-0.14%)
Jun 2, 2026, 10:20 AM EDT - Market open
Fresenius Medical Care AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19,359 | 19,628 | 19,336 | 19,454 | 19,398 | 17,619 | |
Revenue Growth (YoY) | -0.69% | 1.51% | -0.60% | 0.29% | 10.10% | -1.35% |
Cost of Revenue | 14,334 | 14,599 | 14,579 | 14,529 | 14,504 | 12,846 |
Gross Profit | 5,025 | 5,029 | 4,757 | 4,925 | 4,894 | 4,773 |
Selling, General & Admin | 3,031 | 3,033 | 3,143 | 3,196 | 3,170 | 2,773 |
Depreciation & Amortization Expenses | 373 | - | - | - | - | - |
Research & Development | 153.17 | 157.98 | 183.49 | 231.97 | 228.62 | 220.78 |
Other Operating Expenses | -233.73 | -192.56 | -172.82 | -249.05 | -197.7 | -19.3 |
Total Operating Expenses | 3,324 | 2,998 | 3,153 | 3,179 | 3,201 | 2,974 |
Operating Income | 1,496 | 1,827 | 1,392 | 1,369 | 1,512 | 1,852 |
Interest Income | 69.63 | 69.61 | 71.58 | 88.22 | 67.66 | 73.17 |
Interest Expense | -381.98 | -384.41 | -407.04 | -424.64 | -360.14 | -353.6 |
Other Non-Operating Income (Expense) | - | - | - | - | 148.2 | - |
Total Non-Operating Income (Expense) | -312.35 | -314.8 | -335.47 | -336.42 | -144.27 | -280.43 |
Pretax Income | 1,470 | 1,512 | 1,057 | 1,033 | 1,219 | 1,572 |
Provision for Income Taxes | 302.24 | 320.97 | 316.06 | 300.56 | 324.95 | 352.83 |
Net Income | 779.83 | 978.37 | 537.91 | 499 | 673.41 | 969.31 |
Minority Interest in Earnings | 222.81 | 212.9 | 202.96 | 233.46 | 220.92 | 249.72 |
Net Income to Common | 779.83 | 978.37 | 537.91 | 499 | 673.41 | 969.31 |
Net Income Growth | 81.92% | 81.88% | 7.80% | -25.90% | -30.53% | -16.75% |
Shares Outstanding (Basic) | 573 | 582 | 587 | 587 | 586 | 586 |
Shares Outstanding (Diluted) | 573 | 582 | 587 | 587 | 586 | 586 |
Shares Change (YoY) | -2.30% | -0.76% | - | 0.06% | 0.10% | -0.38% |
EPS (Basic) | 1.64 | 1.68 | 0.92 | 0.85 | 1.15 | 1.66 |
EPS (Diluted) | 1.64 | 1.68 | 0.92 | 0.85 | 1.15 | 1.66 |
EPS Growth | 54.72% | 83.61% | 7.65% | -26.09% | -30.51% | -16.41% |
Shares Outstanding | 540.18 | 558.58 | 586.83 | 586.83 | 586.83 | 586.01 |
Free Cash Flow | 1,980 | 1,766 | 1,687 | 1,944 | 1,443 | 1,635 |
Free Cash Flow Growth | 12.13% | 4.67% | -13.24% | 34.70% | -11.73% | -48.60% |
Free Cash Flow Per Share | 3.45 | 3.03 | 2.87 | 3.31 | 2.46 | 2.79 |
Dividends Per Share | 1.490 | 1.490 | 1.440 | 1.190 | 1.120 | 1.350 |
Dividend Growth | - | 3.47% | 21.01% | 6.25% | -17.04% | 0.75% |
Gross Margin | 25.96% | 25.62% | 24.60% | 25.32% | 25.23% | 27.09% |
Operating Margin | 7.73% | 9.31% | 7.20% | 7.04% | 7.79% | 10.51% |
Profit Margin | 5.18% | 6.07% | 3.83% | 3.77% | 4.61% | 6.92% |
FCF Margin | 10.23% | 9.00% | 8.72% | 9.99% | 7.44% | 9.28% |
EBITDA | 3,065 | 3,327 | 3,135 | 3,121 | 3,350 | 3,476 |
EBITDA Margin | 15.83% | 16.95% | 16.21% | 16.05% | 17.27% | 19.73% |
EBIT | 1,496 | 1,827 | 1,392 | 1,369 | 1,512 | 1,852 |
EBIT Margin | 7.73% | 9.31% | 7.20% | 7.04% | 7.79% | 10.51% |
Effective Tax Rate | 20.57% | 21.22% | 29.90% | 29.10% | 26.65% | 22.45% |